$RDHL
Redhill Biopharma Ltd.
XNAS•Health Care•Pharmaceutical Preparations
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateRedhill Biopharma Ltd.
XNAS•Health Care•Pharmaceutical Preparations
Why is RDHL up today? It is at $0.505 (+3.78%), and our scanner flagged it 30 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment RDHL spikes, and full due diligence on RDHL — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $RDHL 30 times in the last 30 days. Create a free account to track $RDHL, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on RDHL from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for RDHL today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystPriced share offering, from the latest SEC filing. Read it →* Institutional ownership was unavailable, so float is insider-deduped only.
The company can keep selling new shares into the market. Size not stated in the filing.
Some filings did not state a size, so these are floors.
At-the-market (ATM) offering active — the company can keep selling new shares into the market over time (ongoing)
87,903,331,000 new shares · At-the-market (ATM) program — sells new shares into the market gradually over time · About $2.6M in size
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Raday Gilead Officer | Sold (automatic/other) | -14.31M 235.3% of company | sold 7.5% | 176.91M | n/a | Oct 1, 26 |
Raday Gilead Officer | Sold (automatic/other) | -14.13M 232.4% of company | sold 6.1% | 218.78M | n/a | Jul 10, 26 |
Raday Gilead Officer | Sold (automatic/other) | -15.74M 258.8% of company | sold 5.7% | 261.06M | n/a | Apr 6, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.



The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on RDHL from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for RDHL today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
RDHL last traded at $0.505, up 3.78% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
The RDHL Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged RDHL 30 times in the last 30 days.
RDHL (Redhill Biopharma Ltd.) trades on XNAS, with a market cap of about $3M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge RDHL for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$RDHL discussion
Sign in to ask a question or join the discussion.